JPS6046085B2 - cosmetics - Google Patents
cosmeticsInfo
- Publication number
- JPS6046085B2 JPS6046085B2 JP13615582A JP13615582A JPS6046085B2 JP S6046085 B2 JPS6046085 B2 JP S6046085B2 JP 13615582 A JP13615582 A JP 13615582A JP 13615582 A JP13615582 A JP 13615582A JP S6046085 B2 JPS6046085 B2 JP S6046085B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- ester
- fatty acid
- polyglycerin
- cosmetics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002537 cosmetic Substances 0.000 title claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 40
- 239000000194 fatty acid Substances 0.000 claims description 40
- 229930195729 fatty acid Natural products 0.000 claims description 40
- 150000004665 fatty acids Chemical class 0.000 claims description 40
- 150000007519 polyprotic acids Polymers 0.000 claims description 35
- 150000002148 esters Chemical class 0.000 claims description 29
- 229920000223 polyglycerol Polymers 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- -1 fatty acid ester Chemical class 0.000 description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 239000000126 substance Substances 0.000 description 18
- 206010015150 Erythema Diseases 0.000 description 17
- 206010030113 Oedema Diseases 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 17
- 231100000321 erythema Toxicity 0.000 description 16
- 238000003756 stirring Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 238000003786 synthesis reaction Methods 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 229910001873 dinitrogen Inorganic materials 0.000 description 12
- 239000012071 phase Substances 0.000 description 11
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 230000007794 irritation Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000007664 blowing Methods 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 239000003513 alkali Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000005639 Lauric acid Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000006386 neutralization reaction Methods 0.000 description 5
- 206010020565 Hyperaemia Diseases 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 206010040914 Skin reaction Diseases 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000035483 skin reaction Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 229940014800 succinic anhydride Drugs 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 2
- 208000019300 CLIPPERS Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 206010057385 Eyelid irritation Diseases 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 210000000554 iris Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 238000013077 scoring method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 description 1
- MXQXWJVQZHHBJV-UHFFFAOYSA-N 7h-purine-2-carboxylic acid Chemical compound OC(=O)C1=NC=C2N=CNC2=N1 MXQXWJVQZHHBJV-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241000517645 Abra Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000001154 Dermoid Cyst Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- MFQCOUZCCXGXCI-UHFFFAOYSA-N butanedioic acid dodecanoic acid Chemical compound C(CCCCCCCCCCC)(=O)O.C(CCC(=O)O)(=O)O.C(CCC(=O)O)(=O)O MFQCOUZCCXGXCI-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 231100000269 corneal opacity Toxicity 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940102253 isopropanolamine Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は、ポリグリセリン脂肪酸エステルと、多塩基酸
とからなるエステル、つまり脂肪酸多塩基酸ポリグリセ
リンエステル及び/又はその塩を配合することを特徴と
する安定で皮膚に安全な化粧料に関するものてある。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a stable and skin-friendly ester comprising a polyglycerin fatty acid ester and a polybasic acid, that is, a fatty acid polybasic acid polyglycerin ester and/or a salt thereof. There is something about safe cosmetics.
医療品、化粧品、および食品用の界面活性剤として有用
である脂肪酸ポリグリセリンエステルは脂肪酸とポリグ
リセリンとをエステル化することによつて得られるが、
母核のポリグリセリンはグリセリンの縮合あるいは、グ
リセリンとグリシドールとの反応で得られ、一般的には
グリセリンの縮合による場合が多い。Fatty acid polyglycerol esters, which are useful as surfactants for medical products, cosmetics, and foods, are obtained by esterifying fatty acids and polyglycerin.
The core polyglycerol is obtained by condensing glycerin or by reacting glycerin with glycidol, and is generally obtained by condensing glycerin.
このように、脂肪酸ポリグリセリンエステルは、グリセ
リンを出発物質としているため、皮フ刺激が低いなど、
安全性が良好であり、また脂肪酸の種類、グリセリンの
重合度、そしてエステル化度を変化させることによつて
親水性親油性バランス(以下HLBと略す)を変えるこ
とが可能なことから、乳化剤、可溶化剤として有用であ
ると考えられてきた。In this way, fatty acid polyglycerin ester uses glycerin as a starting material, so it has low irritation to the skin, etc.
Emulsifiers have good safety, and the hydrophilic-lipophilic balance (hereinafter abbreviated as HLB) can be changed by changing the type of fatty acid, the degree of polymerization of glycerin, and the degree of esterification. It has been considered useful as a solubilizer.
そのため特に化粧料への応用が検討、され、既に脂肪酸
ジグリセリンエステルをはじめとするいくつかの脂肪酸
ポリグリセリンエステルが使用されている。Therefore, the application to cosmetics has been particularly studied, and several fatty acid polyglycerol esters including fatty acid diglycerol esters are already in use.
しカルながら、脂肪酸ポリグリセリンエステルは、化粧
品用界面活性剤として必須条件である皮フ安全性に関し
て、前述のように良好である反面、界面活性能の点につ
いては、従来の界面活性剤と比較すると実際には次に述
べる通りの欠点を有しており、その改善が大いに望まれ
ていた。However, while fatty acid polyglycerol esters have good skin safety, which is an essential condition for cosmetic surfactants, as mentioned above, they are not as good as conventional surfactants in terms of surfactant ability. In reality, however, it has the following drawbacks, and improvement thereof has been highly desired.
(1)高■、Bのものが得られにくい。すなわち脂肪酸
ポリグリセリンエステルの親水性を高める手段は、その
重合度を高め、水酸基を増やすのが、合成時における従
来の手法であるが、重合度を上げる場合極端に粘度が上
昇し、合成が困難であると共に、合成された脂肪酸ポリ
グリセリンエステルの使用性はベタツキが強く使用性が
良くない。これに反し、本発明による脂肪酸多塩基酸ポ
リグリセリンエステルにあつては、粘度の上昇を見るこ
ともなく高■、Bのものまで自由に調整可能である。(
2)’’肌に対するなじみ’’が悪い。(1) High ■, B is difficult to obtain. In other words, the conventional method for increasing the hydrophilicity of fatty acid polyglycerol esters during synthesis is to increase the degree of polymerization and increase the number of hydroxyl groups, but increasing the degree of polymerization causes an extreme increase in viscosity, making synthesis difficult. In addition, the usability of the synthesized fatty acid polyglycerin ester is not good because it is highly sticky. On the contrary, in the case of the fatty acid polybasic acid polyglycerin ester according to the present invention, the viscosity can be freely adjusted to high (1) and B (high B) without any increase in viscosity. (
2) Poor compatibility with the skin.
一般的に非イオン界面活性剤を含有する化粧料は皮フに
使用した場合、アニオン界面活性剤を含有する化粧料に
較べ、その使用感は、厚みのある感じのものが多く、皮
フにすみやかになじんでとけ込んでゆくような使用域を
有していない場合が多い。脂肪酸ポリグリセリンもその
例に漏れず、肌の上に一枚、皮の残るような、なじみの
悪い使用感を有する。これに比較し、本発明の脂肪酸多
塩基酸ポリグリセリンエステル及び/又はその塩ば゜な
じみの良い゛使用感と脂肪酸ポリグリセリンが本来有す
る゜゜粉つぽい゛゛゜さつぱりしだ使用感をあわせ持つ
ている。本発明者らは、かかる現状に鑑み、脂肪酸ポリ
グリセリンエステルの性能向上などの改良を検討した結
果、得られたのが脂肪酸多塩基酸ポリグリセリンエステ
ル及び/又はその塩である。In general, when cosmetics containing nonionic surfactants are used on the skin, they tend to have a thicker feel when used, compared to cosmetics containing anionic surfactants. In many cases, it does not have a range of use where it can be quickly adapted and integrated. Fatty acid polyglycerin is no exception, and has an unpleasant feeling when used, as if a layer of skin remains on the skin. In comparison, the fatty acid polybasic acid polyglycerin ester and/or its salt of the present invention has both the familiar feeling of use and the powdery and crisp feel of fatty acid polyglycerin. ing. In view of the current situation, the present inventors investigated improvements such as improving the performance of fatty acid polyglycerol esters, and as a result, they obtained fatty acid polybasic acid polyglycerol esters and/or salts thereof.
このものは脂肪酸ポリグリセリンエステルと同様、良好
な皮フ安全性を有し、かつ脂肪酸ポリグリセリンエステ
ルでは不可能であつたHLの自由な調整が可能であり、
しかも使用感も肌になじみよいことが認められ、理想的
な化粧品用界面活性剤であることが判明した。そして、
本発明者らは、上記脂肪酸多塩基酸ポリグリセリンを種
々の化粧料に配合し、従来の化粧料にはない、優れた安
全性、安定な乳化性、良好な使用感を兼ねそなえた新規
な化粧料を開発するに至つたのである。すなわち、本発
明は、重合度2〜20のポリグリセリンと炭素数8〜3
0の脂肪酸とからなる脂肪酸ポリグリセリンエステルと
、多塩基酸とを該多塩基酸の酸基が少なくとも1つは遊
離で残るように反応させて得られるエステル及び/又は
その塩を配合することを特徴とする化粧料を提供するも
のである。Like fatty acid polyglycerin esters, this product has good skin safety, and allows for free adjustment of HL, which was not possible with fatty acid polyglycerin esters.
Furthermore, it was found that it felt good on the skin and was found to be an ideal cosmetic surfactant. and,
The present inventors blended the fatty acid polybasic acid polyglycerin into various cosmetics to create a new product that has excellent safety, stable emulsifying properties, and good feeling of use, which are not found in conventional cosmetics. This led to the development of cosmetics. That is, the present invention uses polyglycerin with a degree of polymerization of 2 to 20 and a carbon number of 8 to 3.
A fatty acid polyglycerol ester consisting of 0 fatty acids and a polybasic acid are reacted so that at least one acid group of the polybasic acid remains free. The purpose is to provide cosmetics with special characteristics.
ここで本発明の脂肪酸多塩基酸ポリグリセリンエステル
の理解を深める目的で、ポリグリセリン母核がすべてα
位で重合した、つまり直鎖のポリグリセリンエステルに
ついて一般式を示すと次のようになる。Here, for the purpose of understanding the fatty acid polybasic acid polyglycerol ester of the present invention, it is assumed that all the polyglycerol cores are α
The general formula for a linear polyglycerin ester polymerized at this position is as follows.
上記一般式においてn=2〜20であり、R1、R2・
・・Rn+1は、水素、炭素数8ないし30の脂肪酸残
基、多塩基酸残基、および多塩基酸塩残基のいずれかを
表わし、R1、R2、・・・Rn+1の少なくとも1つ
は炭素数8ないし30の脂肪酸残基で、他の少なくとも
1つは多塩基酸残基もしくは多塩基酸塩残基である。In the above general formula, n=2 to 20, R1, R2・
...Rn+1 represents hydrogen, a fatty acid residue having 8 to 30 carbon atoms, a polybasic acid residue, or a polybasic acid salt residue, and at least one of R1, R2, ...Rn+1 is carbon Among the number of 8 to 30 fatty acid residues, at least one other is a polybasic acid residue or a polybasic acid salt residue.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明に係る脂肪酸多塩基酸ポリグリセリンエステルの
母核のポリグリセリンは、重合度が2〜.20のもので
あり、望ましくは3〜15である。The core polyglycerin of the fatty acid polybasic acid polyglycerin ester according to the present invention has a degree of polymerization of 2 to . 20, preferably 3 to 15.
さらに重合度か高いものも界面活性能は良好であると思
われるが、合成時に系の粘度が上昇し反応が進みにくく
なるという問題がある。又、上記ポリグリセリンは、反
応性の点からα.位で縮重合したものが一般的であるが
、β位で縮合した、つまり分岐ポリグリセリンであつて
も構わない。Furthermore, those with a high degree of polymerization are considered to have good surface activity, but there is a problem that the viscosity of the system increases during synthesis, making it difficult for the reaction to proceed. In addition, the above polyglycerin has α. Generally, it is a polyglycerol condensed at the β position, but it may also be a branched polyglycerin condensed at the β position.
次に、本発明に係る脂肪酸多塩基酸ポリグリセリンエス
テルを構成する脂肪酸は、炭素数8〜30・の直鎖の飽
和および不飽和脂肪酸、および側鎖を有する飽和および
不飽和脂肪酸であつて、例えば、力プリン酸、ラウリン
酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘ
ニン酸、セロチン酸、パルミトレイン酸、オレイン酸、
イソパルミチン酸、イソステアリン酸、ヒドロキシステ
アリン酸、リノール酸、リノレイン酸、リシノール酸、
リシノレイン酸、アビエチン酸などである。Next, the fatty acids constituting the fatty acid polybasic acid polyglycerol ester according to the present invention are linear saturated and unsaturated fatty acids having 8 to 30 carbon atoms, and saturated and unsaturated fatty acids having side chains, For example, puric acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, cerotic acid, palmitoleic acid, oleic acid,
Isopalmitic acid, isostearic acid, hydroxystearic acid, linoleic acid, linoleic acid, ricinoleic acid,
These include ricinoleic acid and abietic acid.
脂肪酸のポリグリセリンへの付加モル数はポリグリセリ
ンの水酸基の数、多塩基酸残基及び多塩基酸塩残基の数
を考慮に入れながら任意に選ぶことができるが、少なく
とも1モルは付加していなければならず、又1モル付加
のものが最も好ましい。本発明に係る脂肪酸多塩基酸ポ
リグリセリンエステルを構成する多塩基酸は、コハク酸
、グルタル酸、アジピン酸、マレイン酸、リンゴ酸、酒
石酸、フタル酸、クエン酸などである。The number of moles of fatty acid added to polyglycerin can be arbitrarily selected taking into consideration the number of hydroxyl groups, polybasic acid residues and polybasic acid salt residues of polyglycerin, but at least 1 mole should be added. and 1 molar addition is most preferred. Polybasic acids constituting the fatty acid polybasic acid polyglycerol ester according to the present invention include succinic acid, glutaric acid, adipic acid, maleic acid, malic acid, tartaric acid, phthalic acid, citric acid, and the like.
多塩基酸の付加モル数も、ポリグリセリンの水酸基の数
、脂肪酸残基の数を勘案しながら任意に選ぶことができ
るが、少なくとも1モル以上は付加していなければなら
ない。The number of moles of the polybasic acid added can also be arbitrarily selected while taking into account the number of hydroxyl groups and the number of fatty acid residues in the polyglycerin, but at least 1 mole or more must be added.
本発明の脂肪酸多塩基酸ポリグリセリンエステルはその
ままでも化粧料に配合できるが、多塩基酸残基を塩基性
物質によつて中和し、さらにHL,Bを高めて使用する
こともできる。The fatty acid polybasic acid polyglycerol ester of the present invention can be blended into cosmetics as it is, but it can also be used by neutralizing the polybasic acid residues with a basic substance to further increase HL and B.
多塩基酸残基を中和する塩基性物質は、水酸化ナトリウ
ム、水酸化カリウム、水酸化リチウムなどの金属水酸化
物、トリエタノールアミン、イソプロパノールアミンな
どの有機アミン、及びアルギニン、リジンなどの塩基性
アミノ酸である。Basic substances that neutralize polybasic acid residues include metal hydroxides such as sodium hydroxide, potassium hydroxide, and lithium hydroxide, organic amines such as triethanolamine and isopropanolamine, and bases such as arginine and lysine. It is a sexual amino acid.
塩基性物質による多塩基酸残基の中和は部分中和でも完
全中和でも良い。又、中和はあらかじめ行つて脂肪酸多
塩基酸ポリグリセリンエステル塩にしてから化粧料に配
合しても良いし、油相に脂肪酸多塩基酸ポリグリセリン
を配合し、水相に塩基性物質を配合して乳化の際に中和
するなど化粧料の製造工程中で中和を行つても良い。上
記脂肪酸多塩基酸ポリグリセリンエステルは一般的には
、以下の方法によつて合成される。Neutralization of polybasic acid residues with a basic substance may be partial neutralization or complete neutralization. Alternatively, neutralization may be performed in advance to form a fatty acid polybasic acid polyglycerin ester salt, which can then be blended into cosmetics, or fatty acid polybasic acid polyglycerin may be blended into the oil phase and a basic substance may be blended into the aqueous phase. Neutralization may be carried out during the manufacturing process of cosmetics, such as during emulsification. The above fatty acid polybasic acid polyglycerin ester is generally synthesized by the following method.
すなわち、ポリグリセリンをアルカリ触媒下、約80℃
〜250゜C(好ましくは180゜C〜230℃)で脂
肪酸エステルにする。次に、このものを酸無水物と80
℃〜250すC(好ましくは180酸C〜2300C)
において多塩基酸でエステル化し、目的の脂肪酸多塩基
酸ポリグリセリンエステルを得る。さらに、このものを
塩基性物質により中和もしくは部分中和すれば、脂肪酸
多塩基酸ポリグリセリンエステル塩が得られる。上記合
成法をさらに詳細に説明するために以下に具体的な合成
例を挙げる。That is, polyglycerin is heated at about 80°C under an alkali catalyst.
Convert to fatty acid ester at ~250°C (preferably 180°C to 230°C). Next, add this material to an acid anhydride and
℃~250℃ (preferably 180℃~2300℃)
The mixture is esterified with a polybasic acid to obtain the target fatty acid polybasic acid polyglycerin ester. Furthermore, if this product is neutralized or partially neutralized with a basic substance, a fatty acid polybasic acid polyglycerin ester salt can be obtained. In order to explain the above synthesis method in more detail, specific synthesis examples are given below.
本発明はこれにより限定されるものではない。合成例−
1
モノラウリン酸ジコハク酸デカグリセリンエステル攪拌
装置、水分採取管を備えた1eの三ツロフラスコにデカ
グリセリン152g1ラウリン酸40.5gおよび、水
酸化ナトリウム0.3gを加えて窒素ガスを吹きこみな
がら、200〜230゜Cに加熱撹拌を行なう。The present invention is not limited thereby. Synthesis example-
1 Monolauric acid disuccinic acid decaglycerin ester Add 152 g of decaglycerin 1 40.5 g of lauric acid and 0.3 g of sodium hydroxide to a Mitsuro flask (1e) equipped with a stirring device and a water sampling tube, and add 200 to 200 g of sodium hydroxide while blowing nitrogen gas. Heat and stir at 230°C.
水分留出量が約3.3m1になつたところで、室温まで
冷却し反応を停止する。ついで、無水コハク酸40.0
gを加え、窒素ガスを吹きこみながら、80〜110℃
で約2時間攪拌を行ない、モノラウリン酸ジコハク酸デ
カグリセリンエステルを得た。When the amount of water distilled reaches approximately 3.3 ml, the reaction is stopped by cooling to room temperature. Then, succinic anhydride 40.0
g and heated to 80-110℃ while blowing nitrogen gas.
The mixture was stirred for about 2 hours to obtain monolaurate disuccinate decaglycerin ester.
本品は室温でワックス状の物質であり、酸価は105.
4であつた。This product is a waxy substance at room temperature and has an acid value of 105.
It was 4.
このものは、そのまま、あるいはアルカリと部分中和、
あるいは完全中和して用いることができる。This product can be used as is or partially neutralized with alkali.
Alternatively, it can be used after being completely neutralized.
合成例−2
モノラウリン酸テトラコハク酸デカグリセリンエステル
攪拌装置、水分採取管を備えた1′の三ツロフラスコに
デカグリセリン152g1ラウリン酸40.5gおよび
、水酸化ナトリウム0.4gを加えて、窒素ガスを吹き
こみながら、200〜230℃に加熱攪拌を行なう。Synthesis Example-2 Monolauric acid tetrasuccinic acid decaglycerin ester In a 1' three-meter flask equipped with a stirring device and a water sampling tube, 152 g of decaglycerin, 40.5 g of lauric acid, and 0.4 g of sodium hydroxide were added, and nitrogen gas was blown into the flask. While stirring, heat and stir at 200 to 230°C.
水分留出量が約3.3mLになつたところで、室温まで
冷却し、反応を停止する。ついで、無水コハク酸80.
1gを加え、窒素ガスを吹きこみながら、80〜110
℃で約2時間攪拌を行ない、モノラウリン酸テトラコハ
ク酸デカグリセリンエステルを得た。When the water distillation amount reaches approximately 3.3 mL, the reaction is stopped by cooling to room temperature. Then, succinic anhydride 80.
Add 1g and heat to 80-110 while blowing in nitrogen gas.
Stirring was carried out at °C for about 2 hours to obtain monolauric acid tetrasuccinic acid decaglycerin ester.
本品は、室温でワックス状の物質であり、酸価は172
.3であつた。このものは、そのまま、あるいは、アル
カリと部分中和、あるいは、完全中和して用いることが
できる。合成例−3
モノラウリン酸ジコハク酸ヘキサグリセリンエステル合
成例1と同様の装置を用いて、ヘキサグリセリン138
.6g1ラウリン酸60.1g1および水酸化ナトリウ
ム0.12gを加えて窒素ガスを吹きこみながら、20
0〜230゜Cに加熱攪拌を行なう。This product is a waxy substance at room temperature and has an acid value of 172.
.. It was 3. This product can be used as it is, or after being partially or completely neutralized with an alkali. Synthesis Example-3 Monolauric acid disuccinic acid hexaglycerin ester Using the same apparatus as in Synthesis Example 1, hexaglycerin 138
.. 6g1 lauric acid 60.1g1 and sodium hydroxide 0.12g were added, and while blowing nitrogen gas, 20
Heat and stir at 0 to 230°C.
水分留出量が、約5.0m1になつたところで、室温ま
で冷却し、反応を停止する。ついで、無水コハク酸60
.1gを加え、窒素ガスを吹きこみながら、80〜11
0℃で約2時間攪拌を行ない、モノラウリン酸ジコハク
酸ヘキサグリセリンエステルを得た。When the amount of water distilled reaches approximately 5.0 ml, the reaction is stopped by cooling to room temperature. Then, succinic anhydride 60
.. Add 1g and blow nitrogen gas until it reaches 80~11.
Stirring was performed at 0° C. for about 2 hours to obtain monolauric acid disuccinic acid hexaglycerin ester.
本品は室温で無色透明の液状物質であり、酸価は138
.1であつた。本品は、そのまま、あるいはアルカリと
部分中和、あるいは完全中和して用いることができる。
合成例−4モノラウリン酸モノグルタール酸デカグリセ
リンエステル合成例−1と同様の反応装置を用いて、デ
カグリセリン227.4g1ラウリン酸64.1gおよ
び水酸化ナトリウム0.6gを加えて、窒素ガスを吹き
こみながら、200〜230℃に加熱攪拌を行なう。This product is a colorless and transparent liquid substance at room temperature, and its acid value is 138.
.. It was 1. This product can be used as is, or partially or completely neutralized with an alkali.
Synthesis Example-4 Monolauric Acid Monoglutaric Acid Decaglycerin Ester Using the same reaction apparatus as in Synthesis Example-1, 227.4 g of decaglycerin, 64.1 g of lauric acid, and 0.6 g of sodium hydroxide were added, and nitrogen gas was blown into the mixture. While heating and stirring at 200 to 230°C.
水分留出量が約5.5WLtになつたところで、室温ま
で冷却フし、反応を停止する。ついで、無水グルタール
酸34.2gを加え、窒素ガスを吹きこみながら、80
〜110℃で約3時間、攪拌を行ない、モノラウリン酸
モノグルタール酸デカグリセリンエステルを得た。When the water distillation amount reaches approximately 5.5 WLt, the reaction is stopped by cooling to room temperature. Next, 34.2 g of glutaric anhydride was added, and the mixture was heated to 80 g while blowing nitrogen gas.
Stirring was performed at ~110°C for about 3 hours to obtain monolauric acid monoglutaric acid decaglycerin ester.
本品は室温で無色透明の液状物質であり、酸価57.8
であつた。本品は、そのまま、あるいはアルカリと部分
中和、あるいは、完全中和して用いることができる。合
成例−5
モノイソステアリン酸モノグルタール酸ヘキサグリセリ
ンエステル合成例−1と同様の装置を用いて、ヘキサグ
リセリン138.6g1イソステアリン酸93.9g1
水酸化ナトリウム0.8gを加えて、窒素ガスを吹きこ
みながら200〜230゜Cに加熱攪拌を行なう。This product is a colorless and transparent liquid substance at room temperature, and has an acid value of 57.8.
It was hot. This product can be used as is, or partially or completely neutralized with an alkali. Synthesis Example-5 Monoisostearic acid monoglutaric acid hexaglycerin ester Using the same apparatus as in Synthesis Example-1, 138.6 g of hexaglycerin 1 93.9 g of isostearic acid
Add 0.8 g of sodium hydroxide, and heat and stir at 200 to 230°C while blowing nitrogen gas.
水分留出量が約5.2mtになつたところで室温まで冷
却し、反応を停止する。ついで、無水グルタール酸35
.4gを加え、窒素ガスを吹きこみながら、80〜11
0℃で約2時間攪拌を行ない、モノイソステアリン酸モ
ノグルタール酸ヘキサグリセリンエステルを得た。When the water distillation amount reaches approximately 5.2 mt, the reaction is stopped by cooling to room temperature. Then, glutaric anhydride 35
.. 80-11 while adding 4g and blowing in nitrogen gas.
Stirring was performed at 0° C. for about 2 hours to obtain monoisostearic acid monoglutaric acid hexaglycerin ester.
本品は室温で殆ど無色の粘稠な物質であり、酸価は69
.8であつた。本品は、そのまま、あるいはアルカリと
部分中和、あるいは完全中和して用いることができる。This product is an almost colorless viscous substance at room temperature, and its acid value is 69.
.. It was 8. This product can be used as is, or partially or completely neutralized with an alkali.
合成例−6モノイソステアリン酸モノアジピン酸デカグ
リセリンエステル合成例−1と同様の装置を用いて、デ
カグリセリン227.4g1イソステアリン酸93.9
g1および、水酸化ナトリウム1.0gを加えて、窒素
ガスを吹きこみながら、200〜230゜Cに加熱攪拌
を行なう。Synthesis Example-6 Monoisostearic acid monoadipate decaglycerin ester Using the same equipment as in Synthesis Example-1, 227.4 g of decaglycerin 93.9 g of isostearic acid
g1 and 1.0 g of sodium hydroxide are added, and the mixture is heated and stirred at 200 to 230°C while blowing nitrogen gas.
水分留出量が約5.5m1になつたところで室温まで冷
却し、反応を停止する。ついで、アジピン酸43.8g
1および水酸化ナトリウムを加えて、窒素ガスを吹きこ
みながら、200〜220゜Cで加熱攪拌を行なう。When the amount of distilled water reaches about 5.5 ml, the reaction is stopped by cooling to room temperature. Next, 43.8g of adipic acid
1 and sodium hydroxide, and heated and stirred at 200 to 220°C while blowing nitrogen gas.
水分留出量が約5m1になつたところで室温まで冷却し
、反応を停止し、モノイソステアリン酸アジピン酸デカ
グリセリンエステルを得た。本品の酸価は56.5であ
つた。When the amount of distilled water reached about 5 ml, the reaction mixture was cooled to room temperature and the reaction was stopped to obtain monoisostearic acid adipic acid decaglycerol ester. The acid value of this product was 56.5.
また、本品は、そのまま、あるいはアルカリと部分中和
、あるいは完全中和して用いることができる。In addition, this product can be used as it is, or after being partially or completely neutralized with an alkali.
本発明においては、前記脂肪酸多塩基酸ポリグリセリン
エステル及び/又はその塩を化粧料中に配合することに
よつて、皮膚に安全で、乳化が良く、使用性に優れた化
粧料を得ることができる。In the present invention, by blending the fatty acid polybasic acid polyglycerol ester and/or its salt into cosmetics, it is possible to obtain cosmetics that are safe for the skin, have good emulsification, and are excellent in usability. can.
得られる化粧料の種類は、基礎化粧料、メイクアップ化
粧料、頭髪化粧料、ボディ用化粧料などいずれも良い。
配合の仕方は化粧料成分の1つとして、たとえば従来の
界面活性剤がとられる方法で配合される。配合量は、従
来の界面活性剤と同様任意に選択できるが一般的には0
.1〜95重量%である。もちろん、脂肪酸多塩基酸ポ
リグリセリンエステル及び/又はその塩は異なる構造の
2種以上を組合せて配合しても良く、その場合の合計配
l合量は、同じく0.1〜95重量%である。以上、詳
述したごとく本発明は、新規な界面活性剤である脂肪酸
多塩基酸ポリグリセリンエステル及び/又はその塩を乳
化剤、あるいは可溶化剤などとして配合した化粧料に関
するものであり、・その皮フ安全性の高さと、多塩基酸
によるエステル化度や多塩基酸の中和度を選択すること
により幅広い界面活性能のものを得られる点および優れ
た使用感により、従来のポリオキシエチレン系非イオン
界面活性剤、アニオン系界面活性剤、カチ”オン系界面
活性剤に較らべ、より安全で、多くの種類の特徴ある化
粧料を作ることが可能である。また本発明における脂肪
酸多塩基酸ポリグリセリンエステルは、良好な安全性を
有するという点から、医薬品用の界面活性剤としても有
用である。以下、本発明をより詳細に説明するために、
試験例、実施例を挙げる、本発明はこれにより限定され
るものではない。The resulting cosmetics may be of any type, including basic cosmetics, makeup cosmetics, hair cosmetics, and body cosmetics.
It is blended as one of the cosmetic ingredients, for example, in the same manner as conventional surfactants. The blending amount can be selected arbitrarily like conventional surfactants, but generally it is 0.
.. It is 1 to 95% by weight. Of course, the fatty acid polybasic acid polyglycerin ester and/or its salt may be blended in combination of two or more types with different structures, and in that case, the total blended amount is also 0.1 to 95% by weight. . As detailed above, the present invention relates to a cosmetic containing a novel surfactant, fatty acid polybasic acid polyglycerol ester and/or its salt, as an emulsifier or solubilizer. Conventional polyoxyethylene-based polyoxyethylene-based Compared to nonionic surfactants, anionic surfactants, and cationic surfactants, it is safer and it is possible to create many types of distinctive cosmetics. Basic acid polyglycerol esters are also useful as surfactants for pharmaceuticals because they have good safety.Hereinafter, in order to explain the present invention in more detail,
Although test examples and examples are given, the present invention is not limited thereto.
試験例
本発明において使用するモノラウリン酸トリコハク酸デ
カグリセリンのトリカリウム塩(PH=7)と、ジャー
ナル オブ フアーマシテイカルサイエンスニ第5?第
1鏝第1164頁、196坪に記載されているSOdi
unllaljrylethersulfate,SO
diumlauryIsulfateについて、以下の
安全性試験を行つた。Test Example The tripotassium salt of monolaurate trisuccinate decaglycerin used in the present invention (PH=7) and the Journal of Pharmaceutical Science No. 5? SOdi described on page 1164 of the first trowel, 196 tsubo
unllaljrylethersulfate,SO
The following safety tests were conducted on diumlauryIsulfate.
1動物テスト
1.1皮膚一次刺激性の検討(FDA法に準じた試験)
試験法;体重2.3k9〜3k9の日本白色種ウサギを
使用する。1 Animal test 1.1 Examination of primary skin irritation (test according to FDA method)
Test method: Japanese white rabbits weighing 2.3k9 to 3k9 are used.
電気バリカンにて背部の毛を刈つた8羽のウサギを4羽
づつ2群に分け、1群はそのまま(IntactSki
n)、他の1群は被験部位にすり傷を作り(,Abra
dedSkin)、固定器に固定する。被験物質を0.
3m11直径2.5cmのリント布のついた動物テスト
用絆創膏を用いて皮膚に貼布する。24時間後に絆創膏
を取り除き、皮膚の反応を判定基準に従つて紅斑と浮腫
の度合を記入する。Eight rabbits whose back hair was trimmed with electric clippers were divided into two groups of four rabbits each, and one group was left alone (IntactSki
n), and the other group had an abrasion on the test site (, Abra
dedSkin) and fixed in a fixator. The test substance was 0.
Apply to the skin using an animal test bandage with a lint cloth of 3m11 diameter 2.5cm. After 24 hours, the bandage is removed, and the degree of erythema and edema is recorded according to the skin reaction criteria.
n時間後に再び判定を行う。判定:
(1)紅斑及び痴皮の形成
紅斑の全く認められないもの ・・・・・0僅
かな紅斑が認められるもの ・・・・・1明ら
かな紅斑が認められるもの ・・・・・2強い紅
斑が認められるもの ・・・・・3強い紅斑
に僅かな痴皮の認められるもの ・・・4(2)浮腫の
形成浮腫の認められないもの ・・・・・
0非常に僅かな浮腫の認められるもの ・・・・・1
僅かな浮腫の認められるもの ・・・・・2中
等度の浮腫の認められるもの ・・・・・3(大
体1W0rL程度)強い浮腫の認められるもの
・・・・・4(1wr1以上及び貼布範囲以外には
み出す)無傷皮膚(IntactSkjn)、有傷皮膚
(AbradedSkin)各4羽についての24、n
時間後の紅斑及び浮腫の形成の判定の平均値とを加え、
これを動物検体数4て割つた平均値で、動物皮膚一次刺
激性の標価を表わす。The determination is made again after n hours. Judgment: (1) Formation of erythema and derma. No erythema at all ... 0 Slight erythema ... 1 Clear erythema ... 2 Those with strong erythema...3 Those with strong erythema and slight derma...4 (2) Formation of edema Those with no edema...
0 Very slight edema is observed...1
Slight edema...2 Moderate edema...3 (approximately 1W0rL) Strong edema
...4 (1wr1 or more and protruding outside the patch area) 24, n for each 4 birds with intact skin (IntactSkjn) and damaged skin (AbradedSkin)
Add the average value of the judgment of the formation of erythema and edema after hours,
The average value obtained by dividing this by the number of animal specimens (4) represents the price of primary animal skin irritation.
被験物質の評価;
(判定基準の平均和)
平均値
2未 満 僅かな刺激性又は殆んど刺激性なし2〜5
中等度の刺激性有り
5以 上 強い刺激性有り
各被験物質の動物皮膚層一次刺激性の結果を表1に示す
。Evaluation of test substance; (average sum of judgment criteria) Average value less than 2 Slight irritation or almost no irritation 2-5
Moderate irritation 5 or higher Strong irritation Table 1 shows the results of primary irritation to the animal skin layer of each test substance.
1.2皮膚累積刺激性の検討
試験法;
体重400〜500gのハートレイ系白色モルモツトを
使用する。1.2 Test method for examining cumulative skin irritation; Hartley white guinea pigs weighing 400 to 500 g are used.
電気バリカンにて背部の毛を刈つた3匹のモルモツトの
皮膚に被験物質0.3mtを、3X4cmの範囲に均一
に塗布する。塗布2@間後に判定基準に従つて皮膚反応
を判定する。判定後、前日と同様の方法で同一部位に2
回目の塗布を行う。0.3 mt of the test substance is evenly applied to the skin of three guinea pigs whose back hair has been shaved with electric clippers in an area of 3 x 4 cm. After application 2, the skin reaction is determined according to the criteria. After the determination, apply 2 in the same area in the same way as the previous day.
Apply the second application.
2鞘間後、皮膚反応の判定を行い、更に3回目の塗布を
行う。After 2 coats, the skin reaction is assessed and a third application is made.
2峙間後、最終判定を行う。After two seconds, a final judgment will be made.
判定:
全く変化の認められないもの ・・・・0僅
かに紅斑が認められるもの ・・・・1明ら
かに紅斑が認められるもの ・・・・2強い紅斑
あるいは僅かな浮腫、痴皮の認められるもの
・・・・3明らかに浮腫、痴皮あるいはそれ以
上の変化の認められるもの ・・・・4動物皮膚
累積刺激性の評価は、2本48.n時間後の判定の総和
を9で割つた平均値で表わす。Judgment: No change at all ... 0 Slight erythema ... 1 Obviously erythema ... 2 Strong erythema, slight edema, or dermoid skin thing
3. Those with obvious edema, dementia, or worse changes 4. Evaluation of cumulative animal skin irritation: 48. It is expressed as the average value obtained by dividing the sum of judgments after n hours by 9.
試験物質の評価平均値 評価 2未 満 僅かな刺激性又は殆んど刺激性なし。Evaluation average value of test substance Evaluation Less than 2 Slight irritation or almost no irritation.
2以 上 刺激性あり。2 or more Irritating.
1.3眼瞼刺激性の検討(Draiz法に準じた試験法
)試験法:
体重2.0kg〜3.5k9の日本白色ウサギを使用す
る。1.3 Examination of eyelid irritation (test method according to Draiz method) Test method: Japanese white rabbits weighing 2.0 kg to 3.5 kg are used.
被験物質0.1m1を3匹のウサギの右眼の結膜のうに
適用する。適用後1時間、4時間、1日、2日、3日、
4日、5日、6日、7日後に、角膜、虹彩、結膜を観察
し、判定は下記の採点法に従つて行う。採点法:
I 角膜
A不透明度
透明 ・・・・0
弱い混濁 ・・・・1
明らかな混濁 ・・・・2
乳白色の混濁 ・・・・3
不透明 ・・・・4
B角膜の混濁
C総計 (A+B)×5
最大理論値=80
■虹彩
Δ 庁的信
正常 ・・・・・0
僅かな充血 ・・・・・1
対光反応なし ・・・・2
B総計A×5
最大理論値=10
■結膜
A発赤
正常 ・・・・・0
明らかな充血 ・・・・1
深紅色の充血 ・・・・2
牛肉様の充血 ・・・・・3
B浮腫
正常 ・・・・0
僅かな浮腫 ・・・・・1
明らかな浮腫 ・・・・・2
眼瞼が約半分閉じる浮腫
・・・・3
眼瞼が約半分以上閉じる
浮腫 ・・・・・4
C流出物
正常 ・・・・・0
僅かな流出物 ・・・・1
明らかな流出物 ・・・・・2
非常に明らかな流出物
・・・・・3
D総計 (A+B+C)X2
実施例1
化粧水
(1)モノラウリン酸ジコハク酸ヘキサ
8 最大理論値=20
眼瞼刺激性の評価は角膜、虹彩、結膜の総不平均値で表
わす。0.1 ml of the test substance is applied to the conjunctival sac of the right eye of three rabbits. 1 hour, 4 hours, 1 day, 2 days, 3 days after application.
After 4, 5, 6, and 7 days, the cornea, iris, and conjunctiva are observed, and judgments are made according to the following scoring method. Scoring method: I Corneal A opacity Transparent ・・・0 Weak opacity ・・・1 Obvious opacity ・・・2 Milky opacity ・・・3 Opaque ・・・4 B Corneal opacity C Total ( A + B) × 5 Maximum theoretical value = 80 ■Iris Δ Officially normal ...0 Slight hyperemia ...1 No reaction to light ...2 Total B total A × 5 Maximum theoretical value = 10 ■Conjunctival A normal redness...0 Obvious hyperemia...1 Deep red hyperemia...2 Beef-like hyperemia...3 B edema normal...0 Slight edema ...1 Obvious edema ...2 Edema in which the eyelids are approximately half closed ...3 Edema in which the eyelids are approximately half closed ...4 C Outflow is normal ...0 Slight Spillage...1 Obvious spillage...2 Very obvious spillage...3 D total (A+B+C)X2 Example 1 Lotion (1) Monolauric acid disuccinate hexa 8 Maximum Theoretical value = 20 The evaluation of eyelid irritation is expressed by the total average value of the cornea, iris, and conjunctiva.
被験物質の評価
5 平均値
1昧満・・・・・・僅かな刺激性、殆んど刺激性なし1
0以上・・・・・・刺激性あり。Evaluation of the test substance 5 Average value 1 Very little irritation, almost no irritation 1
0 or more: Irritating.
2人体閉塞バッチテスト 前腕を使用する。2 human body occlusion batch test Use your forearm.
被験物質0.05m1を直径1.1゛Oのリント布のつ
いた鳥居製薬株式会社製造のノチテスト絆創膏を用いて
皮膚に貼布する。反応判定時間;
判定は2@間閉塞後剥離2〜3時間後に行ザ実施人員;
健康人女子5酩一5反応判定基準;
変化なし ・・−
かすかな紅斑 ・・・・±
紅斑 ・・・・+
紅斑、浮腫又は紅疹 ・・・・++
θ 紅斑、浮腫、水胞 ・・・・+++以下、動
物及び人体安全性試験結果を表HZ25す。0.05 ml of the test substance is applied to the skin using a Nochitest bandage manufactured by Torii Pharmaceutical Co., Ltd. with a lint cloth having a diameter of 1.1゛O. Reaction judgment time: Judgment is performed 2 to 3 hours after the occlusion and the person performing the reaction;
Healthy female 5-5 reaction criteria; No change...- Faint erythema...± Erythema...+ Erythema, edema, or erythema...+++ θ Erythema, edema, vesicles... ... +++ Below, the animal and human safety test results are shown in Table HZ25.
グリセリンのジナトリウム塩
(2)グリセリン 5(3)プロピ
レングリコール 4(4)エタノール
10(5)オレイルアルコール
0.1(6)香料 0.1(7)
バラオキシ安息香酸メチル 0.2(8)紫外線
吸収剤 適量(9)金属イオン封
鎖剤 適量(1a)精製水
78.1(製造法)(10に(1)、
(2)、(3)、(8)、(9)を溶解する。Disodium salt of glycerin (2) Glycerin 5 (3) Propylene glycol 4 (4) Ethanol
10(5) Oleyl alcohol
0.1(6) Fragrance 0.1(7)
Methyl roseoxybenzoate 0.2 (8) Ultraviolet absorber Appropriate amount (9) Sequestering agent Appropriate amount (1a) Purified water
78.1 (Production method) (10 (1),
Dissolve (2), (3), (8), and (9).
次に(4)に(5)、(6)、(7)を溶解し、前記水
溶液中に攪拌しながら添加し、化粧水を得た。実施例2
化粧水状乳液
〔重量%〕(1)
ジプロピレングリコール 3.0(2)1,
3−ブチレングリコール 2.0(3)モノラウリ
ン酸ジグルタル酸 0.8デカグリセリンのモノカ
リウム塩(4) シリコン湘−56(信越化学製)
2.0(5)スクワラン 0.5
(6)エタノール 10.0(7
)香料 0.1(8)精製水
81.6(製造法)(8)に(1)、(2
)、(6)を溶解し、70℃に加熱する。Next, (5), (6), and (7) were dissolved in (4) and added to the aqueous solution with stirring to obtain a lotion. Example 2
Lotion-like emulsion [weight%] (1)
Dipropylene glycol 3.0 (2) 1,
3-Butylene glycol 2.0 (3) Monolauric acid diglutaric acid 0.8 Monopotassium salt of decaglycerin (4) Silicon Xiang-56 (manufactured by Shin-Etsu Chemical)
2.0(5) Squalane 0.5
(6) Ethanol 10.0 (7
) Fragrance 0.1 (8) Purified water
81.6 (Production method) (8) (1), (2)
) and (6) and heated to 70°C.
別に(3)、(4)、(5)、(7)を混合して70℃
で加熱溶解し、前記水溶液中に攪拌しながら添加する。
ホモミキサーで十分に乳化した後、室温に冷却して化粧
水状乳液を得た。実施例3
乳液
〔重量%〕(1)
ジプロピレングリコール 5.0(2)モノ
イソステアリン酸モノアジピ 1.0ン酸モノ酒石酸ド
デカグリセリンのジトリエタノールアミン塩
(3)モノステアリン酸グリセリン 1.0(4
)セタノール 0.5(5)ス
クワラン 10.0(6)バラオ
キシ安息香酸エチル 0.3(7)香料
0.15(8)精製水
82.05(製造法)実施例2に準じる。Separately, mix (3), (4), (5), and (7) at 70°C.
Dissolve it by heating and add it to the aqueous solution while stirring.
After thorough emulsification with a homomixer, the mixture was cooled to room temperature to obtain a lotion-like emulsion. Example 3 Emulsion [wt%] (1)
Dipropylene glycol 5.0 (2) Monoadipi monoisostearate 1.0 Ditriethanolamine salt of dodecaglycerin monotartrate (3) Glycerin monostearate 1.0 (4
) Setanol 0.5 (5) Squalane 10.0 (6) Ethyl roseoxybenzoate 0.3 (7) Fragrance
0.15 (8) Purified water
82.05 (Production method) According to Example 2.
実施例4
0/W型クリーム
〔重量%〕(
1)ジオレイン酸トリコハク酸デカ 2グリセリン(
2)モノオレイン酸グリセリン 1.5(3)
グリセリン 5(4)L.3−ブチ
レングリコール 4(5)バチルアルコール
5(6)スクワラン 1
2(7)オリーブオイル 8(8)ワ
セリン 4(9)固型パラフ
ィン 3[相] バラオキシ安息香酸
メチル 0.1(11)バラオキシ安息香酸ブチ
ル 0.1(12)香料 0.2(1
3)水酸化ナトリウム 0.1(製造法
)実施例2に準じる。Example 4 0/W type cream [wt%] (
1) Dioleic acid trisuccinic acid deca 2 glycerin (
2) Glycerin monooleate 1.5 (3)
Glycerin 5(4)L. 3-Butylene glycol 4(5) Batyl alcohol
5(6) Squalane 1
2 (7) Olive oil 8 (8) Vaseline 4 (9) Solid paraffin 3 [Phase] Methyl rose oxybenzoate 0.1 (11) Butyl rose oxybenzoate 0.1 (12) Fragrance 0.2 (1
3) Sodium hydroxide 0.1 (Production method) Same as Example 2.
実施例5
W/0型ナイトクリーム
(重量%)(1
)ジオレイン酸モノコハク酸ヘキサグリセリン
3.5のモノカリウ
ム塩.(2)ジイソステアリン酸ジグリセリン 1(3
)蜜ロウ 5(4)固型パラフ
ィン605
(5)マイクロクリスタリンワックス 10(6)ワ
セリン 10J(7)スクワ
ラン 35(8)バラオキシ安息
香酸ブチル 0.1(9)ヒビテングルコネート
液 0.1(1CjiEDTA−3Na0.0
1(11)香 料 適量・(
12)精製水 30.29(
製造法)(1)、(2)、(3)、(4)、(5)、(
6)、(7)、(10)、を混合加熱(70℃)し、溶
解する。Example 5 W/0 type night cream (weight%) (1
) dioleic acid monosuccinic acid hexaglycerin
3.5 monopotassium salt. (2) Diglyceryl diisostearate 1 (3)
) Beeswax 5 (4) Solid paraffin 605 (5) Microcrystalline wax 10 (6) Vaseline 10J (7) Squalane 35 (8) Butyl roseoxybenzoate 0.1 (9) Hibitengluconate liquid 0.1 (1CjiEDTA -3Na0.0
1 (11) Flavoring Appropriate amount (
12) Purified water 30.29 (
Manufacturing method) (1), (2), (3), (4), (5), (
6), (7), and (10) are mixed and heated (70°C) to dissolve.
別に、(8)、(9)、(11゛)を混合溶解して70
℃に加熱し、前記油相成分中に添加)攪拌する。ホモミ
キサーによつて乳化した後、室温まで冷却し、W/O型
ナイトクリームを得た。実施例6乳化型フアンデーシヨ
ン
(重量%)(1
)モノパルミチン酸モノステアリン酸モノコハク
2酸ヘキサグリセリンのモノナトリウム塩(2)ステ
アリン酸 2(3)セトステアリル
アルコール 1.2(4)ワセリン
2(5)ラノリン
0.5(6)グリセロールトリ2−エチルヘキサノエ
ート 10(7)
ビタミンEアセテート 0.1(8)バラ
オキシ安息香酸ブチル 0.2(9)プロピレン
グリコール 7(1a)ポリエチレングリコ
ール60006(11)゛カルボキシメチルセルロース
ナトリウム 1(
12)ベントナイト 0.1(1
3)トリエタノールアミン 1(10酸化チ
タン 9(15)タルク
6
(16)着色顔料 1(17)
香料 0.5(18)精製水
50.37(製造法)(9)、(1CjI
、(11)を(18)に溶解し、次いで(12)、(1
4)、(15)、(16)をこれに添加し、ホモミキサ
ーによつて均一に分散させる。Separately, mix and dissolve (8), (9), and (11゛) for 70 minutes.
℃ and stirred (added to the oil phase components). After emulsifying with a homomixer, the mixture was cooled to room temperature to obtain a W/O type night cream. Example 6 Emulsified foundation (wt%) (1
) monopalmitic acid monostearic acid monosuccinic acid
Monosodium salt of hexaglycerin diacid (2) Stearic acid 2 (3) Cetostearyl alcohol 1.2 (4) Vaseline
2(5) Lanolin
0.5(6) Glycerol tri2-ethylhexanoate 10(7)
Vitamin E Acetate 0.1 (8) Butyl Baroxybenzoate 0.2 (9) Propylene Glycol 7 (1a) Polyethylene Glycol 60006 (11) Sodium Carboxymethyl Cellulose 1 (
12) Bentonite 0.1 (1
3) Triethanolamine 1 (10 titanium oxide 9 (15) talc
6 (16) Colored pigment 1 (17)
Fragrance 0.5 (18) Purified water
50.37 (Production method) (9), (1CjI
, (11) is dissolved in (18), then (12), (1
4), (15), and (16) are added to this and uniformly dispersed using a homomixer.
その後(13)を添加溶解して、これを粉末/水相成分
相とする。別に(1)、(2)、(3)、(4)、(5
)、(6)、(7)、(8)、(17)を混合し、70
′Cに加熱溶解して油相とする。Thereafter, (13) is added and dissolved to form a powder/water phase component phase. Separately (1), (2), (3), (4), (5
), (6), (7), (8), (17) and mix 70
'C to form an oil phase.
粉末/水相成分相を同じく70′Cに加熱し、これに油
相を添加混合してホモミキサーにより乳化する。室温に
まで冷却して乳化型フアウンデイシヨンを得た。実施例
7
ノぐツク
(重量%)(1
)モノイソステアリン酸モノグルタル酸2ヘキサグリセ
リンのモノイソプロパノールアミン塩
1(2)変性アルコール 9(3)ポ
リエチレングリコール40003(4)オリーブ油
4(5)酢酸ビニル樹脂エマシヨ
ン 10(6)ポリビニルアルコール
10(7)重炭酸ナトリウム 0.
05(8)酸化チタン 13(9
)バラオキシ安息香酸メチル 0.2[相] 香
料 適量(11)精製水
48.75(製造法)(1
1)の一部に(8)を添加し、ホモミキサーで均一に分
散し、粉末分散相とする。The powder/aqueous component phase is also heated to 70'C, and the oil phase is added thereto and mixed and emulsified using a homomixer. An emulsified foundation was obtained by cooling to room temperature. Example 7 Nogutsuku (weight%) (1
) Monoisopropanolamine salt of monoisostearate monoglutarate 2 hexaglycerin 1 (2) Denatured alcohol 9 (3) Polyethylene glycol 40003 (4) Olive oil
4(5) Vinyl acetate resin emulsion 10(6) Polyvinyl alcohol
10(7) Sodium bicarbonate 0.
05(8) Titanium oxide 13(9)
) Methyl roseoxybenzoate 0.2 [phase] Flavor Appropriate amount (11) Purified water
48.75 (manufacturing method) (1
Add (8) to a portion of 1) and uniformly disperse with a homomixer to form a powder dispersed phase.
別に(11)に(6)、(7)を溶解し、さらに加熱溶
解した(3)と(7)を添加して溶解し、最後に(5)
を加えて均一に攪拌して、これを水相とする。水相と粉
末分散相を混合し、これに(2)に溶解した(1)、(
4)、(9)、(10を添加して均一に攪拌する。得ら
れたバックは不透明ゲル状で、肌にマイルドで使用感、
経日安定性ともに良好なものであつた。Separately, (6) and (7) were dissolved in (11), then heated and dissolved (3) and (7) were added and dissolved, and finally (5)
Add and stir evenly to form the aqueous phase. The aqueous phase and powder dispersed phase were mixed, and (2) was dissolved in (1), (
Add 4), (9), and (10) and stir evenly.The resulting bag is in the form of an opaque gel, and has a mild feel on the skin.
Both stability over time was good.
Claims (1)
の脂肪酸とからなる脂肪酸ポリグリセリンエステルと多
塩基酸とを、該多塩基酸の酸基が少なくとも一つは遊離
で残るように反応させて得られるエステル及び/又はそ
の塩を配合することを特徴とする化粧料。1 Polyglycerin with a degree of polymerization of 2 to 20 and carbon number of 8 to 30
It is characterized by blending an ester and/or a salt thereof obtained by reacting a fatty acid polyglycerol ester consisting of a fatty acid with a polybasic acid so that at least one acid group of the polybasic acid remains free. cosmetics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13615582A JPS6046085B2 (en) | 1982-08-04 | 1982-08-04 | cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13615582A JPS6046085B2 (en) | 1982-08-04 | 1982-08-04 | cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5927807A JPS5927807A (en) | 1984-02-14 |
| JPS6046085B2 true JPS6046085B2 (en) | 1985-10-14 |
Family
ID=15168595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13615582A Expired JPS6046085B2 (en) | 1982-08-04 | 1982-08-04 | cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6046085B2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61194007A (en) * | 1985-02-22 | 1986-08-28 | Shiseido Co Ltd | External preparation for skin |
| GB9220667D0 (en) † | 1992-09-30 | 1992-11-11 | Unilever Plc | Improvements in or relating to dioic acids |
| JP3466252B2 (en) * | 1993-12-27 | 2003-11-10 | 日清オイリオ株式会社 | Cosmetics |
| CN1116862C (en) * | 1997-11-14 | 2003-08-06 | 藤泽药品工业株式会社 | Water-in-oil emulsifier composition |
| JP5143354B2 (en) * | 2005-11-22 | 2013-02-13 | 日本精化株式会社 | Oligomer ester and cosmetics and skin external preparations containing these |
| JP6660885B2 (en) | 2014-11-17 | 2020-03-11 | 阪本薬品工業株式会社 | Powder dispersant, powder dispersion composition containing the same and cosmetics |
| KR20240153562A (en) * | 2022-02-24 | 2024-10-23 | 닛신 오일리오그룹 가부시키가이샤 | Oligoester, and cosmetic containing the oligoester |
| EP4506331A4 (en) | 2022-03-25 | 2025-10-01 | Taiyo Kagaku Kk | COMPOUND WITH POLYGLYCEROL, FATTY ACID AND DICARBOXYLIC ACID ESTERIFIED |
| WO2023181682A1 (en) * | 2022-03-25 | 2023-09-28 | 太陽化学株式会社 | Compound in which polyglycerol, fatty acid, and dicarboxylic acid have been esterified |
-
1982
- 1982-08-04 JP JP13615582A patent/JPS6046085B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5927807A (en) | 1984-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7427640B1 (en) | Oil materials comprising dimerdiol ester and cosmetics comprising the ester | |
| JP2831800B2 (en) | Oil-soluble N-long-chain acyl acidic amino acid esters, mixtures thereof and cosmetics containing them | |
| JP2003226609A (en) | Lanolin-like compositions and cosmetics and external preparations containing them | |
| JPS6046085B2 (en) | cosmetics | |
| US5474778A (en) | Cosmetic and an external preparation containing an oil-soluble n-long chained acyl acidic amino acid ester | |
| JPH08310941A (en) | Oil-in-water type emulsified cosmetic for sunscreen | |
| JPH1053625A (en) | Acrylic acid polymer and emulsion composition containing the same | |
| JP3444366B2 (en) | Emulsion composition | |
| JP3902174B2 (en) | Method for producing oil-in-water emulsion composition | |
| JP2006273752A (en) | Oil-in-water type foam-containing cosmetic | |
| JPS59161309A (en) | Emulsified cosmetic | |
| JP2006131603A (en) | Cinnamic acid derivative, its application as ultraviolet absorber, ultraviolet-absorbing composition formulated therewith, and skin care preparation for external use | |
| CA2138049C (en) | Microemulsified hair treatment products and methods of making same | |
| JPS6338969B2 (en) | ||
| JP4834236B2 (en) | Silicone derivatives and oils, cosmetics and external preparations containing the same | |
| JP3426413B2 (en) | Cosmetics | |
| JPS58223436A (en) | Emulsion composition | |
| JPH0930925A (en) | Skin cosmetic | |
| JPH0399004A (en) | Skin cosmetic | |
| JPS6338970B2 (en) | ||
| JPH10316523A (en) | Oil-in-water type emilsified composition | |
| JPS6230546A (en) | Polybasic acid type bio-surfactant emulsified composition | |
| JP2003026530A (en) | Cosmetics and external preparations | |
| JPH0374315A (en) | Esterified product and cosmetic or external drug containing the same | |
| JP3426406B2 (en) | Cosmetics |